SK Bioscience Co Ltd (302440) — Free Cash Flow Generation Index
SK Bioscience Co Ltd (302440) has a Free Cash Flow Generation Index of -2.44x as of September 2025. Free cash flow of ₩-50.29 Billion represents -2% of operating cash flow (₩20.65 Billion). Read SK Bioscience Co Ltd (302440) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SK Bioscience Co Ltd Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for SK Bioscience Co Ltd across 5 annual periods. Explore 302440 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for SK Bioscience Co Ltd (2018–2023)
Year-by-year Free Cash Flow Generation Index for SK Bioscience Co Ltd. For the full company profile including market capitalisation, see 302440 market cap overview.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.71x | ₩-20.95 Billion | ₩29.35 Billion | ₩50.30 Billion | ▼ -177.8% |
| 2021 | 0.92x | ₩492.12 Billion | ₩536.59 Billion | ₩42.91 Billion | ▲ +0.2% |
| 2020 | 0.92x | ₩110.03 Billion | ₩120.22 Billion | ₩9.93 Billion | ▲ +594.7% |
| 2019 | -0.19x | ₩-4.04 Billion | ₩21.82 Billion | ₩23.97 Billion | ▼ -132.1% |
| 2018 | 0.58x | ₩8.59 Billion | ₩14.90 Billion | ₩6.31 Billion | — |